Age-Related Macular Degeneration Diagnostic Test Co-Development

In 2007, Toronto-based Arctic Dx set out to translate compelling research on the genetic basis of age-related macular degeneration (AMD) into a prognostic test they could market in the United States. Their search for a CLIA lab with expertise in molecular diagnostics led them to National Jewish Health Advanced Diagnostic Laboratories.

The two organizations quickly formed a partnership, and within 4 months launched Macula Risk®, a laboratory developed test (LDT) to assess the risk of AMD progression from early or intermediate AMD to advanced AMD.

As a result of this strategic partnership, Arctic Dx and Advanced Diagnostic Laboratories have developed a formidable alliance based on the successful commercialization and adoption of AMD testing by optometrists and ophthalmologists throughout the United States.

For more information on strategic partnership opportunities with Advanced Diagnostic Laboratories, please contact our sales team.